CD44: a cancer stem cell marker and therapeutic target in leukemia treatment

被引：10
|
作者：
Wu, Shuang [1 ,2 ]
Tan, Yicheng [1 ,2 ,3 ]
Li, Fanfan [2 ,3 ,4 ]
Han, Yixiang [2 ,3 ,5 ]
Zhang, Shenghui [1 ,2 ,3 ,4 ]
Lin, Xiaofei [4 ]
机构：
[1] Wenzhou Med Univ, Lab Anim Ctr, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Hematol, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Key Lab Hematol, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Cent Lab, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
CD44; leukemia; adhesion; migration; homing; differentiation; biomarkers; clinical application; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HYALURONAN-CD44; INTERACTION; ADHESION MOLECULES; SOLUBLE CD44; BONE-MARROW; POOR-PROGNOSIS; ERM PROTEINS; SERUM CD44; EXPRESSION;
D O I：
10.3389/fimmu.2024.1354992
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CD44 is a ubiquitous leukocyte adhesion molecule involved in cell-cell interaction, cell adhesion, migration, homing and differentiation. CD44 can mediate the interaction between leukemic stem cells and the surrounding extracellular matrix, thereby inducing a cascade of signaling pathways to regulate their various behaviors. In this review, we focus on the impact of CD44s/CD44v as biomarkers in leukemia development and discuss the current research and prospects for CD44-related interventions in clinical application.
引用
收藏
页数：16
相关论文
共 50 条
  • [1] The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
    Thapa, Ranjeeta
    Wilson, George D.
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [2] CD44 as a potential therapeutic target and prognosis marker for glioblastoma
    Wang, Fengfei
    Shen, Xin
    Pruszynski, Jessica
    Huang, Jason
    Kirmani, Batool
    Wu, Erxi
    Fonkem, Ekokobe
    CANCER RESEARCH, 2016, 76
  • [3] CD44: a potential therapeutic target in chronic myeloid leukemia
    Shi, Rui
    Liu, Xinle
    PHARMAZIE, 2021, 76 (12): : 574 - 578
  • [4] CD44: More than a mere stem cell marker
    Morath, I.
    Hartmann, T. N.
    Orian-Rousseau, V.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 81 : 166 - 173
  • [5] Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis
    Wang, Wei
    Dong, Li-Ping
    Zhang, Ning
    Zhao, Cheng-Hai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12): : 5059 - 5066
  • [6] Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
    Takaishi, Shigeo
    Okumura, Tomoyuki
    Tu, Shuiping
    Wang, Sophie S. W.
    Shibata, Wataru
    Vigneshwaran, Ramanathan
    Gordon, Shanisha A. K.
    Shimada, Yutaka
    Wang, Timothy C.
    STEM CELLS, 2009, 27 (05) : 1006 - 1020
  • [7] CD26 a cancer stem cell marker and therapeutic target
    Davies, Samuel
    Beckenkamp, Aline
    Buffon, Andreia
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 71 : 135 - 138
  • [8] CD44 as a tumor biomarker and therapeutic target
    Xu, Hanxiao
    Niu, Mengke
    Yuan, Xun
    Wu, Kongming
    Liu, Aiguo
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
  • [9] CD44 as a tumor biomarker and therapeutic target
    Hanxiao Xu
    Mengke Niu
    Xun Yuan
    Kongming Wu
    Aiguo Liu
    Experimental Hematology & Oncology, 9
  • [10] CD44, a therapeutic target for metastasising tumours
    Orian-Rousseau, Veronique
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) : 1271 - 1277
12345